BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16249762)

  • 1. [Results of treating uveal melanoma with proton beam radiation: 10-year follow-up].
    Hamrouni Z; Levy C; Lumbroso L; D'Hermies F; Frau E; Mazal A; Delacroix S; Nauraye C; Dendale R; Schlienger P; Desjardins L
    J Fr Ophtalmol; 2005 Oct; 28(8):833-9. PubMed ID: 16249762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
    Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
    J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
    Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive risk factors for radiation retinopathy and optic neuropathy after proton beam therapy for uveal melanoma.
    Seibel I; Cordini D; Hager A; Tillner J; Riechardt AI; Heufelder J; Davids AM; Rehak M; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1787-92. PubMed ID: 27376824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
    Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
    Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque radiotherapy for large posterior uveal melanomas (> or =8-mm thick) in 354 consecutive patients.
    Shields CL; Naseripour M; Cater J; Shields JA; Demirci H; Youseff A; Freire J
    Ophthalmology; 2002 Oct; 109(10):1838-49. PubMed ID: 12359604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma.
    Akbaba S; Foerster R; Nicolay NH; Arians N; Bostel T; Debus J; Hauswald H
    Radiat Oncol; 2018 Aug; 13(1):140. PubMed ID: 30071857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
    Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eye retention after proton beam radiotherapy for uveal melanoma.
    Egger E; Zografos L; Schalenbourg A; Beati D; Böhringer T; Chamot L; Goitein G
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):867-80. PubMed ID: 12605964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients.
    Shields CL; Shields JA; Cater J; Gündüz K; Miyamoto C; Micaily B; Brady LW
    Arch Ophthalmol; 2000 Sep; 118(9):1219-28. PubMed ID: 10980767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement.
    Gündüz K; Shields CL; Shields JA; Cater J; Freire JE; Brady LW
    Arch Ophthalmol; 1999 Feb; 117(2):170-7. PubMed ID: 10037560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of proton beam irradiation for treatment of choroidal melanoma].
    Lumbroso L; Levy C; Plancher C; Frau E; D'hermies F; Schlienger P; Dendale R; Mammar H; Delacroix S; Nauraye C; Noel G; Ferrand R; Desblancs C; Mazal A; Validire P; Asselain B; Desjardins L
    J Fr Ophtalmol; 2002 Mar; 25(3):290-7. PubMed ID: 11941255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual Outcomes of Parapapillary Uveal Melanomas Following Proton Beam Therapy.
    Thariat J; Grange JD; Mosci C; Rosier L; Maschi C; Lanza F; Nguyen AM; Jaspart F; Bacin F; Bonnin N; Gaucher D; Sauerwein W; Angellier G; Hérault J; Caujolle JP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):328-335. PubMed ID: 27084650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
    Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal Evolution and Dose-Volume Histogram Predictors of Visual Acuity After Proton Beam Radiation Therapy of Uveal Melanoma.
    Polishchuk AL; Mishra KK; Weinberg V; Daftari IK; Nguyen JM; Cole TB; Quivey JM; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):91-97. PubMed ID: 27838186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up after uveal melanoma charged particle therapy.
    Char DH; Kroll SM; Castro J
    Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of uveal melanoma by accelerated proton beam.
    Desjardins L; Lumbroso-Le Rouic L; Levy-Gabriel C; Cassoux N; Dendale R; Mazal A; Delacroix S; Sastre X; Plancher C; Asselain B
    Dev Ophthalmol; 2012; 49():41-57. PubMed ID: 22042012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
    Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
    Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
    Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
    J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma.
    Summanen P; Immonen I; Kivelä T; Tommila P; Heikkonen J; Tarkkanen A
    Br J Ophthalmol; 1996 Aug; 80(8):732-9. PubMed ID: 8949719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.